Literature DB >> 28843543

Microglia and macrophages differ in their inflammatory profile after permanent brain ischemia.

Juan G Zarruk1, Andrew D Greenhalgh1, Samuel David2.   

Abstract

We studied the expression of pro- and anti-inflammatory molecules in microglia and infiltrating monocyte-derived macrophages after permanent Middle Cerebral Artery Occlusion (pMCAO). LysM-EGFP knock-in mice were used to distinguish between these two cell types, as peripheral myeloid cells are LysM-EGFP+, while microglia are not. This was confirmed with P2ry12 (a microglial specific marker), Iba-1 and EGFP immunostaining. The peak of LysM-EGFP+ myeloid cell infiltration was 72h post-ischemia, and were distributed evenly in the lesion core, surrounded by a dense region of microglia. Flow cytometry showed that a higher percentage of microglia expressed TNF-α at 3 (24.3% vs 1.4%) and 7 (18.8% vs 3.4%) days post-pMCAO as compared to infiltrating macrophages. Microglia and macrophages were purified by fluorescence activated cell sorting 72h post-ischemia to assess the mRNA expression of inflammatory markers. Macrophages upregulated expression of mRNA for arginase-1 (Arg-1) by 1000-fold, and IL-1β by 90-fold as compared to microglia. At the protein level, a significantly number of macrophages expressed Arg-1, while few if any microglia expressed Arg-1. However, IL-1β protein was not detected in macrophages by flow cytometry or immunofluorescence labeling of tissue sections. It was, however, detected in astrocytes along the lesion border. A PCR-array screen of 84 inflammatory genes revealed that pro-inflammatory chemokines and cytokines were predominantly upregulated in macrophages but down-regulated in microglia in the ischemic brain. Our results show clear differences in the inflammatory expression profiles between microglia and macrophages 72h post-ischemia which may shape repair and pro-regenerative mechanisms after stroke.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brain ischemia; Cytokines; Experimental ischemia; IL-1β; Inflammation; Ischemic stroke; LysM-EGFP knock-in mouse; Macrophage; Microglia; TNF-α

Mesh:

Substances:

Year:  2017        PMID: 28843543     DOI: 10.1016/j.expneurol.2017.08.011

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  52 in total

Review 1.  Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil-platelet interactions.

Authors:  Alicia García-Culebras; Violeta Durán-Laforet; Carolina Peña-Martínez; Iván Ballesteros; Jesús M Pradillo; Jaime Díaz-Guzmán; Ignacio Lizasoain; María A Moro
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-21       Impact factor: 6.200

2.  Sustained Increases in Immune Transcripts and Immune Cell Trafficking During the Recovery of Experimental Brain Ischemia.

Authors:  Wen Fury; Keun Woo Park; Zhuhao Wu; Eunhee Kim; Moon-Sook Woo; Yu Bai; Lynn E Macdonald; Susan D Croll; Sunghee Cho
Journal:  Stroke       Date:  2020-07-09       Impact factor: 7.914

Review 3.  Angiogenesis in the ischemic core: A potential treatment target?

Authors:  Masato Kanazawa; Tetsuya Takahashi; Masanori Ishikawa; Osamu Onodera; Takayoshi Shimohata; Gregory J Del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-06       Impact factor: 6.200

Review 4.  Immune cell regulation of glia during CNS injury and disease.

Authors:  Andrew D Greenhalgh; Sam David; F Chris Bennett
Journal:  Nat Rev Neurosci       Date:  2020-02-10       Impact factor: 34.870

Review 5.  The Arginase Pathway in Neonatal Brain Hypoxia-Ischemia.

Authors:  Jana Krystofova; Praneeti Pathipati; Jeffrey Russ; Ann Sheldon; Donna Ferriero
Journal:  Dev Neurosci       Date:  2019-04-17       Impact factor: 2.984

Review 6.  Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.

Authors:  Lu-Yao Ao; Yun-Yi Yan; Lin Zhou; Cheng-Yuan Li; Wan-Ting Li; Wei-Rong Fang; Yun-Man Li
Journal:  J Mol Neurosci       Date:  2018-10-01       Impact factor: 3.444

7.  Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease.

Authors:  Kwang Soo Kim; Paul C Marcogliese; Jungwoo Yang; Steve M Callaghan; Virginia Resende; Elizabeth Abdel-Messih; Connie Marras; Naomi P Visanji; Jana Huang; Michael G Schlossmacher; Laura Trinkle-Mulcahy; Ruth S Slack; Anthony E Lang; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-14       Impact factor: 11.205

Review 8.  Microglia as therapeutic targets after neurological injury: strategy for cell therapy.

Authors:  M Collins Scott; Supinder S Bedi; Scott D Olson; Candice M Sears; Charles S Cox
Journal:  Expert Opin Ther Targets       Date:  2021-06-01       Impact factor: 6.902

9.  Microglia-derived interleukin-10 accelerates post-intracerebral hemorrhage hematoma clearance by regulating CD36.

Authors:  Qian Li; Xi Lan; Xiaoning Han; Frederick Durham; Jieru Wan; Abigail Weiland; Raymond C Koehler; Jian Wang
Journal:  Brain Behav Immun       Date:  2021-02-13       Impact factor: 7.217

10.  Neuroprotective Effects of Chrysin Mediated by Estrogenic Receptors Following Cerebral Ischemia and Reperfusion in Male Rats.

Authors:  Maryam Khombi Shooshtari; Yaghoob Farbood; Seyed Mohammad Taghi Mansouri; Mohammad Badavi; Laya Sadat Khorsandi; Mohammad Ghasemi Dehcheshmeh; Ali Reza Sarkaki
Journal:  Basic Clin Neurosci       Date:  2021-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.